The antiviral drug likely has a gradient of benefit, with those at highest risk most likely to see the greatest benefit, experts say in an editorial.
Among fully vaccinated, study shows Paxlovid does not shorten symptoms
Published in COVID-19
May 2, 2024
The International Organization for the Proctection Against COVID-19
The antiviral drug likely has a gradient of benefit, with those at highest risk most likely to see the greatest benefit, experts say in an editorial.
Published in COVID-19